Does the SMART2 risk score accurately predict recurrent ASCVD events in patients with established ASCVD?
The SMART2 algorithm provides a validated, quantitative tool to personalize secondary prevention strategies by estimating residual risk of recurrent ASCVD events.
The SMART2 risk score provides an updated, validated tool for the prediction of recurrent ASCVD events in patients with established ASCVD across European and non-European populations. The use of this tool could allow for a more personalized approach to secondary prevention based upon quantitative rather than qualitative estimates of residual risk.
Hageman et al. (Mon,) studied this question.